Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;11(5):314-21.
doi: 10.1111/j.1399-5448.2009.00601.x.

Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes

Deborah A Elder  1 , Jessica G Woo, David A D'Alessio
Affiliations

Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes

Deborah A Elder et al. Pediatr Diabetes. 2010 Aug.

Abstract

Background: Adults with type 2 diabetes mellitus (T2DM) have broad impairments in beta-cell function, including severe attenuation of the first-phase insulin response to glucose, and reduced beta-cell mass. In adolescents with T2DM, there is some evidence that beta-cell dysfunction may be less severe. Our objective was to determine beta-cell sensitivity to glucose and maximal insulin secretory capacity (AIR(max)) in teenagers with T2DM.

Methods: Fifteen adolescents with T2DM [11 F/4 M, age 18.4 +/- 0.3 yr, body mass index (BMI) 39.8 +/- 2.2 kg/m(2)] and 10 non-diabetic control subjects (7 F/3 M, age 17.4 +/- 0.5 yr, BMI 41.5 +/- 2.2 kg/m(2)) were studied. T2DM subjects had a mean duration of diabetes of 48.8 +/- 6.4 months, were treated with conventional therapies, and had good metabolic control [hemoglobin A1c (HbA1c) 6.7 +/- 1.2%]. Insulin and C-peptide were determined before and after a graded glucose infusion and after intravenous arginine at a whole blood glucose level of >or=22 mM.

Results: The insulin response to increasing plasma glucose concentrations was blunted in the diabetic compared with control subjects (34.8 +/- 11.9 vs. 280.5 +/- 57.8 pmol/mmol; p < 0.0001), and AIR(max) was also significantly reduced in the diabetic group (1868 +/- 330 vs. 4445 +/- 606; p = 0.0005).

Conclusion: Even adolescents with well-controlled T2DM have severe impairments of insulin secretion. These data support beta-cell dysfunction as central in the pathogenesis of T2DM in young people, and indicate that these abnormalities can develop over a period of just several years.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Glycemic and hormone responses to graded glucose infusion. Mean ± standard error of the mean (SEM) presented for each time point. (A) Circulating glucose, (B) insulin, and (C) C-peptide. Symbols used within figures: black triangles represent controls and black circles represent subjects with type 2 diabetes mellitus (T2DM).
Fig. 2
Fig. 2
A) Insulin response to circulating glucose. Predicted slopes and 95% confidence limits presented from longitudinal mixed model. Black triangles represent controls and black circles represent subjects with type 2 diabetes mellitus (T2DM). Inset: estimates of the slope [±standard error (SE)] between insulin and circulating glucose. B) C-peptide response to circulating glucose. Predicted slopes and 95% confidence limits presented from longitudinal mixed model. Black triangles represent controls and black circles represent subjects with T2DM. Inset: estimates of the slope (±SE) between C-peptide and circulating glucose.
Fig. 3
Fig. 3
AIRmax in diabetic and control subjects. A) Insulin response to arginine. Mean ± standard error of the mean (SEM) presented for each time point. Black triangles represent controls and black circles represent subjects with type 2 diabetes mellitus (T2DM). B) AIRmax by subject group.
See this image and copyright information in PMC

References

    1. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005;116:473–480. - PubMed
    1. Bobo N, Evert A, Gallivan J, et al. An update on type 2 diabetes in youth from the National Diabetes Education Program. Pediatrics. 2004;114:259–263. - PubMed
    1. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999–2002. Arch Pediatr Adolesc Med. 2006;160:523–528. - PubMed
    1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. Jama. 2004;291:2847–2850. - PubMed
    1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. Jama. 2006;295:1549–1555. - PubMed

Publication types

MeSH terms